OPTOMED Aktie

 

At Vision Expo 2026 in Orlando, Optomed will showcase the Optomed Lumo, a handheld, non-mydriatic fundus camera designed to support efficient retinal image capture and documentation across clinical care settings. For added flexibility, the device is available with an optional desktop base. The Optomed Lumo combines a 12 MP high-sensitivity sensor with Smart Autofocus™ technology and customizable workflows to support the acquisition of high-quality retinal images without dilation. Key Features · User-Focused Design: 5” touchscreen with guided user interface to support efficient image...

Optomed Plc Stock Exchange Release 27 February 2026 at 9.00, Helsinki Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings Optomed Plc (“Optomed” or the “Company”) has received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act (as amended, the “SMA”) from OP-Rahastoyhtiö Oy (“Notifier”). According to the notification, the total holdings in Optomed shares and votes held the by the Notifier is 4.99 per cent of all of the registered shares in Optomed on 25 February 2026.   The total number...

Optomed Plc        Stock Exchange Release   10 February 2026 at 9.00, Helsinki Optomed Plc: Financial Statements Bulletin January – December 2025 October – December 2025 · Revenue decreased by 5.6 percent to EUR 4.8 (5.1) million. The company received a large order of EUR 1.5 million during the comparison period. · Currency-adjusted revenue decreased by 3.9 percent. · Devices segment revenue decreased by 6.7 percent to EUR 2.4 (2.6) million. Segment revenue during Q3 2025 was EUR 2.3 million. · Devices segment currency-adjusted revenue decreased by 3.3 percent. ·...

Optomed Plc Press Release 3 February 2026 at 9.00, Helsinki Optomed's Financial Statements Bulletin will be published on 10 February 2026 Optomed will publish its Financial Statements Bulletin 2025 on 10 February 2026 approximately at 9.00 EET.   A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest.   The participants are requested to register for the call in advance by email...

Optomed Plc Stock Exchange Release 29 January 2026 at 13:30, Helsinki Proposal of Optomed's Nomination Board Optomed's Nomination Board proposes the following to the next Annual General Meeting:   Number of Board members The Nomination Board proposes, that the number of members of the Board of Directors for the term expiring at the end of the Annual General Meeting 2027 is eight.   Composition of the Board of Directors The Nomination Board proposes to the Annual General Meeting that Sameer Badlani, Catherine Calarco, Ty Lee, Seppo Mäkinen, Petri Salonen, Reijo...

Optomed Plc Press Release 21 Jan 2026 at 11.00, Helsinki   Optomed Achieves ISO 27001 Certification for Information Security Management Systems Optomed, a global leader in AI-enabled handheld retinal screening technology, is proud to announce that it has achieved ISO 27001 certification, the internationally recognized standard for Information Security Management Systems (ISMS). ISO 27001 is a globally accepted framework for managing sensitive company and customer information, ensuring confidentiality, integrity, and availability of data through robust risk management practices...

Optomed Plc Press Release 12 January 2026 at 9.00, Helsinki   Optomed and Aireen Announce Strategic Partnership and Achieve Approval for AI-Powered Handheld Diabetic Retinopathy Screening Optomed and Aireen a.s., a pioneer in AI-driven medical diagnostics, today announced a strategic partnership to deliver AI-powered handheld imaging solutions. As part of this collaboration, Optomed's flagship handheld fundus camera, Optomed Lumo®, has been approved for integration with Aireen's AI algorithm for diabetic retinopathy screening in the EU market.  This regulatory milestone enables...

OPTOMED PLC STOCK EXCHANGE RELEASE 12 December 2025, at 3.45 p.m. EET   New shares subscribed for in Optomed Plc's directed share issue have been registered in the Finnish Trade Register A total of 1,760,000 new shares subscribed for in Optomed Plc's directed share issue have been registered into the Finnish Trade Register today, on 12 December 2025. After the registration of the new shares, the company will have 21,453,297 shares in total of which 22,042 shares in treasury. The new shares produce the right to dividends and other distribution of assets as well as other...

OPTOMED PLC INSIDE INFORMATION   10 December 2025, at 10 p.m. EET   Inside information: Optomed Plc successfully completes directed share issue raising approximately EUR 6.0 million NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. The Board of Directors (the “Board”) of Optomed Plc (“...

Optomed PlcStock Exchange Release 6 November 2025 at 9.00, Helsinki Optomed Plc: Interim Report, January – September 2025   July– September 2025   · Revenue increased by 42.1 percent to EUR 4.4 (3.1) million. · Currency-adjusted revenue growth was 47.0 percent. · Devices segment revenue increased by 183.6 percent to EUR 2.3 (0.8) million. · Devices segment currency-adjusted revenue growth was 202.5 percent. · Software segment revenue decreased by 8.0 percent to EUR 2.1 (2.3) million. · EBITDA amounted to EUR -0.5 (-0.8) million corresponding to -12.1 (-26.2)...

Optomed Plc Press Release 30 October 2025 at 9.00, Helsinki Optomed's January-September 2025 interim report will be published on 6 November 2025 Optomed will publish its January-September 2025 interim report on 6 November 2025 approximately at 9.00 EET.   A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest.   The participants are requested to register for the call in advance...

Optomed, a global leader in handheld fundus imaging, celebrates its fifth consecutive year at the American College of Veterinary Ophthalmologists (ACVO) Annual Conference, held October 15–18, 2025, in Grapevine, Texas. The company will showcase its flagship handheld fundus camera, the Aurora IQ, at Booth #44. Designed for portability and ease of use, the Aurora IQ delivers high-quality retinal imaging even in challenging clinical situations, earning praise from veterinary professionals nationwide. Optomed's continued participation at ACVO underscores its commitment to advancing veterinary eye...

Optomed Plc - Managers' Transactions – 26 September 2025 at 16.30 EET Optomed Plc - Managers' transactions - Himberg ____________________________________________ Person subject to the notification requirement Name: Himberg, Juho Position: Chief Executive Officer Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250926113812_71 ____________________________________________ Transaction date: 2025-09-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT...

Optomed Plc - Managers' Transactions – 26 September  2025 at 16.30 EET Optomed Plc - Managers' transactions - Myllylä ____________________________________________ Person subject to the notification requirement Name: Myllylä, Markku Position: Other senior manager Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250926113812_73 ____________________________________________ Transaction date: 2025-09-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT...

Optomed Plc - Managers' Transactions – 26 September 2025 at 16.30 EET Optomed Plc - Managers' transactions - Piila ____________________________________________ Person subject to the notification requirement Name: Piila, Laura Position: Other senior manager Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250926113812_72 ____________________________________________ Transaction date: 2025-09-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT...

Optomed Plc - Managers' Transactions – 26 September  2025 at 16.30 EET Optomed Plc - Managers' transactions - Knuutti ____________________________________________ Person subject to the notification requirement Name: Knuutti, Sakari Position: Chief Financial Officer Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250926113812_74 ____________________________________________ Transaction date: 2025-09-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT...

Optomed Plc Stock Exchange Release 23 September 2025 at 9.00, Helsinki Optomed's Board has resolved upon a new option plan Optomed's board of directors has resolved upon a new option plan. The resolution is based on the authorization given by the general meeting of 9 May 2025.   Option plan 2025A: The total number of options is 190,000 and each option entitled to one share of the company. The options are offered to certain key employees. The purpose of the plan is to retain and incentifize the CEO and certain other key employees. The subscription price is EUR 3.77. The...

Optomed Plc Stock Exchange Release 9 September 2025 at 9.30, Helsinki Composition of Optomed's Nomination Board According to Optomed's shareholder register of 1st of September 2025, the shareholders represented in the shareholders' Nomination Board are OP-Rahastoyhtiö Oy (OP funds), SP-Rahastoyhtiö Oy (SP Funds) and Danske Invest Rahastoyhtiö Oy (Danske Funds). These shareholders have appointed the following persons to the Nomination Board:   · Vesa Vanha-Honko, OP funds · Petteri Vaarnanen, SP funds · Ville Kivipelto, Danske Funds Petri Salonen, Chairman of Optomed's...

Optomed Plc    Stock Exchange Release    8 August 2025 at 15.30, Helsinki   Optomed Plc - Managers' transactions - Tauriainen ____________________________________________ Person subject to the notification requirement Name: Tauriainen, Reijo Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_65 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN:...

Optomed Plc    Stock Exchange Release    8 August 2025 at 15.30, Helsinki   Optomed Plc - Managers' transactions - Badlani ____________________________________________ Person subject to the notification requirement Name: Badlani, Sameer Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250808112311_60 ____________________________________________ Transaction date: 2025-08-08 Venue not applicable Instrument type: SHARE ISIN:...